153 related articles for article (PubMed ID: 34358353)
21. RCOR1 directly binds to MED28 and weakens its inducing effect on cancer stem cell-like activity of oral cavity squamous cell carcinoma cells.
Xiang Z; Zhou S; Liang S; Zhang G; Tan Y
J Oral Pathol Med; 2020 Sep; 49(8):741-750. PubMed ID: 32306431
[TBL] [Abstract][Full Text] [Related]
22. San-Zhong-Kui-Jian-Tang Exerts Antitumor Effects Associated With Decreased Cell Proliferation and Metastasis by Targeting ERK and the Epithelial-Mesenchymal Transition Pathway in Oral Cavity Squamous Cell Carcinoma.
Hsu PY; Chen JL; Kuo SL; Wang WL; Jan FW; Yang SH; Yang CY
Integr Cancer Ther; 2022; 21():15347354221134921. PubMed ID: 36404765
[TBL] [Abstract][Full Text] [Related]
23. Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma.
Lu X; Wang Z; Huang H; Wang H
J Oral Pathol Med; 2020 Oct; 49(9):897-906. PubMed ID: 32512620
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin-induced HSF1-HSP90 axis enhances the expression of functional PD-L1 in oral squamous cell carcinoma.
Sasaya T; Kubo T; Murata K; Mizue Y; Sasaki K; Yanagawa J; Imagawa M; Kato H; Tsukahara T; Kanaseki T; Tamura Y; Miyazaki A; Hirohashi Y; Torigoe T
Cancer Med; 2023 Feb; 12(4):4605-4615. PubMed ID: 36200687
[TBL] [Abstract][Full Text] [Related]
25. TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma.
Wang YQ; Wu DH; Wei D; Shen JY; Huang ZW; Liang XY; Cho WCS; Ma J; Lv J; Chen YP
Sci Adv; 2023 Jan; 9(1):eadd0960. PubMed ID: 36608137
[TBL] [Abstract][Full Text] [Related]
26. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
Chen L; Zhu Q; Lu L; Liu Y
Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
[TBL] [Abstract][Full Text] [Related]
27. Cancer stemness of CD10-positive cells regulated by Hedgehog pathway promotes the resistance to cisplatin in oral squamous cell carcinoma.
Wang Y; Li Q; Xu L; Chen J; Pu Y; Wang L; Sun H; Guo Y; Guo C
Oral Dis; 2021 Sep; 27(6):1403-1411. PubMed ID: 33037760
[TBL] [Abstract][Full Text] [Related]
28. p22phox confers resistance to cisplatin, by blocking its entry into the nucleus.
Hung CC; Chien CY; Chiang WF; Lin CS; Hour TC; Chen HR; Wang LF; Ko JY; Chang CH; Chen JY
Oncotarget; 2015 Feb; 6(6):4110-25. PubMed ID: 25686830
[TBL] [Abstract][Full Text] [Related]
29. DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma.
Pomella S; Cassandri M; Melaiu O; Marampon F; Gargari M; Campanella V; Rota R; Barillari G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768994
[TBL] [Abstract][Full Text] [Related]
30. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
[TBL] [Abstract][Full Text] [Related]
31. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
Vossen DM; Verhagen CVM; Verheij M; Wessels LFA; Vens C; van den Brekel MWM
Oral Oncol; 2018 Jun; 81():35-44. PubMed ID: 29884412
[TBL] [Abstract][Full Text] [Related]
32. [Insight into the role of IGF2BP1 in drug resistant mechanism of oral squamous cell carcinoma].
Xie F; Qin X; Tong T; Jiang YY; Zhang JJ
Shanghai Kou Qiang Yi Xue; 2021 Oct; 30(5):456-461. PubMed ID: 34888594
[TBL] [Abstract][Full Text] [Related]
33. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
Wang J; Jia J; Zhou L
Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
[TBL] [Abstract][Full Text] [Related]
35. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
36. Functional roles of the SHCBP1 and KIF23 interaction in modulating the cell-cycle and cisplatin resistance of head and neck squamous cell carcinoma.
Sun Y; Pan H; He Y; Hu C; Gu Y
Head Neck; 2022 Mar; 44(3):591-605. PubMed ID: 34918847
[TBL] [Abstract][Full Text] [Related]
37. Bromodomain-containing protein 4 inhibition improves the efficacy of cisplatin and radiotherapy in oral squamous cell carcinoma by suppressing programmed cell death-ligand 1 expression.
Ren J
Basic Clin Pharmacol Toxicol; 2024 Feb; 134(2):272-283. PubMed ID: 38014458
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic modifications control loss of adhesion and aggressiveness of cancer stem cells derived from head and neck squamous cell carcinoma with intrinsic resistance to cisplatin.
Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida LO
Arch Oral Biol; 2022 Sep; 141():105468. PubMed ID: 35679799
[TBL] [Abstract][Full Text] [Related]
40. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma.
Yan J; Xu H
Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
